HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues

Review of the national external quality assessment (EQA) scheme for breast pathology in the UK

(2016) Emad A Rakha et al.   JOURNAL OF CLINICAL PATHOLOGY

Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients

(2016) Marius Ilie et al.   VIRCHOWS ARCHIV

Optimizing HER2 assessment in breast cancer: application of automated image analysis

(2015) Henrik Holten-Rossing et al.   BREAST CANCER RESEARCH AND TREATMENT

New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images

(2015) Jia-Mei Chen et al.   Scientific Reports

Observer Performance in the Use of Digital and Optical Microscopy for the Interpretation of Tissue-Based Biomarkers

(2015) Marios A. Gavrielides et al.   Analytical Cellular Pathology

Molecular pathways and therapeutic targets in lung cancer

(2015) Emma Shtivelman et al.   Oncotarget

Updated UK Recommendations for HER2 assessment in breast cancer

(2014) Emad A Rakha et al.   JOURNAL OF CLINICAL PATHOLOGY

Digital pathology and image analysis in tissue biomarker research

(2014) Peter W. Hamilton et al.   METHODS

Predictive Biomarkers and Companion Diagnostics. The Future of Immunohistochemistry

(2014) Clive R. Taylor   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

A Prospective, Multi-Institutional Diagnostic Trial to Determine Pathologist Accuracy in Estimation of Percentage of Malignant Cells

(2013) Hollis Viray et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

The estimation of tumor cell percentage for molecular testing by pathologists is not accurate

(2013) Alexander J J Smits et al.   MODERN PATHOLOGY

ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry

(2012) Vilppu J Tuominen et al.   HISTOPATHOLOGY

Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains

(2011) Anja Brügmann et al.   BREAST CANCER RESEARCH AND TREATMENT